These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22330614)

  • 1. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
    Ulmer H; Bjørge T; Concin H; Lukanova A; Manjer J; Hallmans G; Borena W; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stattin P; Tretli S; Kleiner A; Stocks T; Nagel G
    Gynecol Oncol; 2012 May; 125(2):330-5. PubMed ID: 22330614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.
    Bjørge T; Lukanova A; Tretli S; Manjer J; Ulmer H; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Jonsson H; Häggström C; Stattin P; Engeland A
    Int J Epidemiol; 2011 Dec; 40(6):1667-77. PubMed ID: 21984693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
    Nagel G; Bjørge T; Stocks T; Manjer J; Hallmans G; Edlinger M; Häggström C; Engeland A; Johansen D; Kleiner A; Selmer R; Ulmer H; Tretli S; Jonsson H; Concin H; Stattin P; Lukanova A
    Br J Dermatol; 2012 Jul; 167(1):59-67. PubMed ID: 22530854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.
    Bjørge T; Lukanova A; Jonsson H; Tretli S; Ulmer H; Manjer J; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Häggström C; Stattin P; Engeland A
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1737-45. PubMed ID: 20615887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).
    Lindkvist B; Almquist M; Bjørge T; Stocks T; Borena W; Johansen D; Hallmans G; Engeland A; Nagel G; Jonsson H; Selmer R; Diem G; Häggström C; Tretli S; Stattin P; Manjer J
    Cancer Causes Control; 2013 Jan; 24(1):107-16. PubMed ID: 23149498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
    Borena W; Strohmaier S; Lukanova A; Bjørge T; Lindkvist B; Hallmans G; Edlinger M; Stocks T; Nagel G; Manjer J; Engeland A; Selmer R; Häggström C; Tretli S; Concin H; Jonsson H; Stattin P; Ulmer H
    Int J Cancer; 2012 Jul; 131(1):193-200. PubMed ID: 21805476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can).
    Almquist M; Johansen D; Björge T; Ulmer H; Lindkvist B; Stocks T; Hallmans G; Engeland A; Rapp K; Jonsson H; Selmer R; Diem G; Häggström C; Tretli S; Stattin P; Manjer J
    Cancer Causes Control; 2011 May; 22(5):743-51. PubMed ID: 21380729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study on metabolic factors and risk of prostate cancer.
    Häggström C; Stocks T; Ulmert D; Bjørge T; Ulmer H; Hallmans G; Manjer J; Engeland A; Nagel G; Almqvist M; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
    Cancer; 2012 Dec; 118(24):6199-206. PubMed ID: 23090855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure and other metabolic syndrome factors and risk of brain tumour in the large population-based Me-Can cohort study.
    Edlinger M; Strohmaier S; Jonsson H; Bjørge T; Manjer J; Borena WT; Häggström C; Engeland A; Tretli S; Concin H; Nagel G; Selmer R; Johansen D; Stocks T; Hallmans G; Stattin P; Ulmer H
    J Hypertens; 2012 Feb; 30(2):290-6. PubMed ID: 22179083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and endometrial carcinoma.
    Bjørge T; Stocks T; Lukanova A; Tretli S; Selmer R; Manjer J; Rapp K; Ulmer H; Almquist M; Concin H; Hallmans G; Jonsson H; Stattin P; Engeland A
    Am J Epidemiol; 2010 Apr; 171(8):892-902. PubMed ID: 20219764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).
    Häggström C; Stocks T; Rapp K; Bjørge T; Lindkvist B; Concin H; Engeland A; Manjer J; Ulmer H; Selmer R; Tretli S; Hallmans G; Jonsson H; Stattin P
    Int J Cancer; 2011 Apr; 128(8):1890-8. PubMed ID: 20568111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can).
    Nagel G; Stocks T; Späth D; Hjartåker A; Lindkvist B; Hallmans G; Jonsson H; Bjørge T; Manjer J; Häggström C; Engeland A; Ulmer H; Selmer R; Concin H; Stattin P; Schlenk RF
    Ann Hematol; 2012 Oct; 91(10):1519-31. PubMed ID: 22588328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can).
    Stocks T; Lukanova A; Bjørge T; Ulmer H; Manjer J; Almquist M; Concin H; Engeland A; Hallmans G; Nagel G; Tretli S; Veierød MB; Jonsson H; Stattin P;
    Cancer; 2011 Jun; 117(11):2398-407. PubMed ID: 24048787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan.
    Inoue M; Noda M; Kurahashi N; Iwasaki M; Sasazuki S; Iso H; Tsugane S;
    Eur J Cancer Prev; 2009 Jun; 18(3):240-7. PubMed ID: 19491612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic risk score and cancer risk: pooled analysis of seven cohorts.
    Stocks T; Bjørge T; Ulmer H; Manjer J; Häggström C; Nagel G; Engeland A; Johansen D; Hallmans G; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
    Int J Epidemiol; 2015 Aug; 44(4):1353-63. PubMed ID: 25652574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project.
    Johansen D; Stocks T; Jonsson H; Lindkvist B; Björge T; Concin H; Almquist M; Häggström C; Engeland A; Ulmer H; Hallmans G; Selmer R; Nagel G; Tretli S; Stattin P; Manjer J
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2307-17. PubMed ID: 20826833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.